CPRX
Companies
NASDAQ
Catalyst Pharmaceuticals Inc.
Health Care
$22.81
Price Chart
Overview
About CPRX
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.
Market Cap
$1.8B
Volume
35.1M
Avg. Volume
34.1M
P/E Ratio
14.562914
Dividend Yield
0.00%
Employees
119.0
Company Information
Latest News for CPRX
Risk & Correlation Analysis
Market Correlation
N/A
N/A
Volatility
N/A
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, CPRX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.8B
Volume35.1M
P/E Ratio14.56
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 27, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025